Evidence map›Paper›PMID 41006354›Full record

ArticleScientific data2025

TrialBench: Multi-Modal AI-Ready Datasets for Clinical Trial Prediction.

Jintai Chen, Yaojun Hu, Mingchen Cai, Yingzhou Lu, Yue Wang, Xu Cao, Miao Lin, Hongxia Xu, Jian Wu, Xiao Cao and 6 more

Abstract readDataset
In one paragraph

Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Artificial Intelligence Across the Drug Development Lifecycle.Medical sciences (Basel, Switzerland) · 2026
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jintai Chen *AI Thrust, Information Hub, HKUST(GZ), Guangzhou, Guangdong, China. jintaiCHEN@hkust-gz.edu.cn.ORCID 0000-0002-3199-2597
Yaojun Hu *College of Computer Science and Technology, Zhejiang University, Hangzhou, Zhejiang, China.
Mingchen CaiAI Thrust, Information Hub, HKUST(GZ), Guangzhou, Guangdong, China.
Yingzhou LuSchool of Medicine, Stanford University, Stanford, CA, USA.ORCID 0009-0008-7774-6018
Yue WangCollege of Computer Science and Technology, Zhejiang University, Hangzhou, Zhejiang, China.
Xu CaoComputer Science Department, UIUC, Champaign, IL, USA.
Miao LinMedical Big Data Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Hongxia XuInnovation Institute for Artificial Intelligence in Medicine of Zhejiang University, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China.
Jian WuThe Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Xiao CaoGE HealthCare, Chicago, IL, USA.
Jimeng SunComputer Science Department, UIUC, Champaign, IL, USA.
Yuqiang LiShanghai Artificial Intelligence Laboratory, Shanghai, China.ORCID 0000-0001-6756-6154
Lucas GlassIQVIA, Boston, MA, USA.
Kexin HuangComputer Science Department, Stanford University, Stanford, CA, USA.ORCID 0000-0001-6693-8390
Marinka ZitnikDepartment of Biomedical Informatics, Harvard Medical School, Harvard University, Boston, MA, USA.ORCID 0000-0001-8530-7228
Tianfan FuState Key Laboratory for Novel Software Technology at Nanjing University, School of Computer Science, Nanjing University, Nanjing, Jiangsu, China. futianfan@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical trials are pivotal for developing new medical treatments but typically carry risks such as patient mortality and enrollment failure that waste immense efforts spanning over a decade. Applying artificial intelligence (AI) to predict key events in clinical trials holds great potential for providing insights to guide trial designs. However, complex data collection and question definition requiring medical expertise have hindered the involvement of AI thus far. This paper tackles these challenges by presenting a comprehensive suite of 23 meticulously curated AI-ready datasets covering multi-modal input features and 8 crucial prediction challenges in clinical trial design, encompassing prediction of trial duration, patient dropout rate/event, serious adverse event, mortality event, trial approval outcome, trial failure reason, drug dose, and design of eligibility criteria. Furthermore, we provide basic validation methods for each task to ensure the datasets' usability and reliability. We anticipate that the availability of such open-access datasets will catalyze the development of advanced AI approaches for clinical trial design, ultimately advancing clinical trial research and accelerating medical solution development.

Indexed as

Artificial IntelligenceClinical Trials as TopicHumansResearch Design

Identifiers

PMID41006354
PMCPMC12475113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.